Govt failed to get FAC okay for Yettinahole project: Petitioner

Shivamogga, May 12: As many as six medical staff members, attached to the Shivamogga district hospital, who were members of the Corona Warriors team, were suspended for raising concerns over inadequate facilities, available to the frontline workers.

According to official sources, among the six, who were suspended by the Hospital Director, included three staff nurses and other supporting staff in the hospital.

The cause for the retaliation with punishment, was following concerns raised by the medical staff over aweful facilities, made available to them by the Hospital authorities.

Byndoor, Jul 16: Byndoor Police Station in Kundapur taluk of Udupi District, has been sealed for the second time in a month, after three personnel including an ASI were tested positive for Covid-19 on Thursday.

All the three including a lady Home Guard have been admitted to the designated Covid Hospital.

Last month the Station was sealed after staff had tested positive.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.